Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 515

    1.

    ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats.

    Coppey LJ, Davidson EP, Rinehart TW, Gellett JS, Oltman CL, Lund DD, Yorek MA.

    Diabetes. 2006 Feb;55(2):341-8.PMID: 16443766 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Treatment of streptozotocin-induced diabetic rats with AVE7688, a vasopeptidase inhibitor: effect on vascular and neural disease.

    Davidson EP, Kleinschmidt TL, Oltman CL, Lund DD, Yorek MA.

    Diabetes. 2007 Feb;56(2):355-62.PMID: 17259379 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on streptozotocin-induced diabetic nephropathy.

    Sen S, Kanter M, Ustundag S, Aktas C, Dogutan H, Yalcin O.

    Ren Fail. 2008;30(10):1023-33. Erratum in: Ren Fail. 2009;31(2):180. Saniye, Sen [corrected to Sen, Saniye]; Mehmet, Kanter [corrected to Kanter, Mehmet]; Sedat, Ustundag [corrected to Ustundag, Sedat]; Cevat, Aktas [corrected to Aktas, Cevat]; Omer, Yalcin [corrected to Yalcin, Omer]. PMID: 19016156 [PubMed - indexed for MEDLINE]Related articles

    6.

    Changes in endoneurial blood flow, motor nerve conduction velocity and vascular relaxation of epineurial arterioles of the sciatic nerve in ZDF-obese diabetic rats.

    Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Yorek MA.

    Diabetes Metab Res Rev. 2002 Jan-Feb;18(1):49-56.PMID: 11921418 [PubMed - indexed for MEDLINE]Related articles

    7.

    Vascular and neural dysfunction in Zucker diabetic fatty rats: a difficult condition to reverse.

    Oltman CL, Davidson EP, Coppey LJ, Kleinschmidt TL, Lund DD, Adebara ET, Yorek MA.

    Diabetes Obes Metab. 2008 Jan;10(1):64-74. Epub 2007 Oct 29.PMID: 17970755 [PubMed - indexed for MEDLINE]Related articles

    8.

    Nerve conduction velocity and evoked potential latencies in streptozotocin-diabetic rats: effects of treatment with an angiotensin converting enzyme inhibitor.

    Manschot SM, Gispen WH, Kappelle LJ, Biessels GJ.

    Diabetes Metab Res Rev. 2003 Nov-Dec;19(6):469-77.PMID: 14648806 [PubMed - indexed for MEDLINE]Related articles

    9.

    Enalapril improves impairment of SERCA-derived relaxation and enhancement of tyrosine nitration in diabetic rat aorta.

    Taguchi K, Kobayashi T, Hayashi Y, Matsumoto T, Kamata K.

    Eur J Pharmacol. 2007 Feb 5;556(1-3):121-8. Epub 2006 Nov 17.PMID: 17196960 [PubMed - indexed for MEDLINE]Related articles

    10.

    Enalapril improves vascular and cardiac function in streptozotocin-diabetic rats.

    Crespo MJ, Dunbar DC.

    Cell Mol Biol (Noisy-le-grand). 2003 Dec;49(8):1311-8.PMID: 14984003 [PubMed - indexed for MEDLINE]Related articles

    11.

    Attenuation of vascular/neural dysfunction in Zucker rats treated with enalapril or rosuvastatin.

    Oltman CL, Davidson EP, Coppey LJ, Kleinschmidt TL, Lund DD, Yorek MA.

    Obesity (Silver Spring). 2008 Jan;16(1):82-9.PMID: 18223617 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.

    Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Lund DD, Salvemini D, Yorek MA.

    Br J Pharmacol. 2001 Sep;134(1):21-9.PMID: 11522593 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunction.

    Oltman CL, Davidson EP, Coppey LJ, Kleinschmidt TL, Yorek MA.

    Diabetes Obes Metab. 2009 Mar;11(3):223-33. Epub 2008 Jun 16.PMID: 18564175 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats.

    Kalender B, Oztürk M, Tunçdemir M, Uysal O, Dagistanli FK, Yegenaga I, Erek E.

    Acta Histochem. 2002;104(2):123-30.PMID: 12086332 [PubMed - indexed for MEDLINE]Related articles

    15.

    Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve.

    Coppey LJ, Davidson EP, Dunlap JA, Lund DD, Yorek MA.

    Int J Exp Diabetes Res. 2000;1(2):131-43.PMID: 11469397 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.
    17.

    Possible role of VEGF in the progression of kidney disease in streptozotocin (STZ)-induced diabetic rats: effects of an ACE inhibitor and an angiotensin II receptor antagonist.

    Kakizawa H, Itoh Y, Imamura S, Matsumoto T, Ishiwata Y, Ono Y, Yamamoto K, Kato T, Hayakawa N, Oda N, Goto Y, Goto Y, Nagasaka A, Senda T, Itoh M.

    Horm Metab Res. 2004 Jul;36(7):458-64.PMID: 15305228 [PubMed - indexed for MEDLINE]Related articles

    18.

    Role of angiotensin II in endothelial dysfunction induced by lipopolysaccharide in mice.

    Lund DD, Brooks RM, Faraci FM, Heistad DD.

    Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3726-31. Epub 2007 Oct 26.PMID: 17965276 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Effects of eugenol on nerve and vascular dysfunction in streptozotocin-diabetic rats.

    Nangle MR, Gibson TM, Cotter MA, Cameron NE.

    Planta Med. 2006 May;72(6):494-500.PMID: 16773532 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effect of treatment of diabetic rats with dehydroepiandrosterone on vascular and neural function.

    Yorek MA, Coppey LJ, Gellett JS, Davidson EP, Bing X, Lund DD, Dillon JS.

    Am J Physiol Endocrinol Metab. 2002 Nov;283(5):E1067-75.PMID: 12376336 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data